📰 Rob Iannone News
Page 7 - Rob Iannone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Iannone. Real-time updates on events, politics, business and more.
June 28, 2022
Nabiximols oromucosal spray continues to be evaluated in ongoing clinical trials in multiple sclerosis spasticity DUBLIN, June 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq:
June 15, 2022
Jazz Pharmaceuticals and Redx announce that pan-RAF inhibitor will enter clinical development - News - PharmaTimes
May 26, 2022
/PRNewswire/ -- Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis, Alzheimers,...
May 26, 2022
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 26, 2022 /PRNewswire/ -- Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such
May 12, 2022
Key data includes ASCO oral presentation of data from the Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Phase 2/3 trial in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN
May 10, 2022
Jazz Pharmaceuticals has acquired development and commercialization rights in the United States for Sumitomo's investigational DSP-0187.
May 4, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2022, raised 2022 financial guidance and...
May 4, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President, and CEO:...
May 4, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2022, raised 2022 financial guidance and...
May 4, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President, and CEO:...